Viewing Study NCT01871558


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-03-04 @ 12:03 PM
Study NCT ID: NCT01871558
Status: COMPLETED
Last Update Posted: 2016-04-21
First Post: 2013-06-04
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus (T2DM) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None type 2 diabetes View
None basal insulin View
None vildagliptin View